Sun, C., Lu, B., Liu, Y., Zhang, Y., Wei, H., Hu, X., . . . Cheng, R. (2021). Reduced Effectiveness and Comparable Safety in Biweekly vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial. Frontiers Media S.A.
Style de citation Chicago (17e éd.)Sun, Chengjun, et al. Reduced Effectiveness and Comparable Safety in Biweekly Vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial. Frontiers Media S.A, 2021.
Style de citation MLA (8e éd.)Sun, Chengjun, et al. Reduced Effectiveness and Comparable Safety in Biweekly Vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial. Frontiers Media S.A, 2021.